Adicet Bio, Inc. (ACET)
↓ Download CSVKey ratios (FY2025)
-73.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$122.11M | -$127.61M | -$152.04M | -$72.55M | -$61.43M | -$39.19M | -$31.39M | -$14.96M | -$18.88M | — |
| Net Income | -$116.80M | -$117.12M | -$142.66M | -$69.79M | -$62.00M | -$36.68M | -$28.14M | -$9.30M | -$33.78M | — |
| EPS (Diluted) | $-16.95 | $-21.33 | $-3.31 | $-1.70 | $-2.00 | — | — | — | — | — |
| Total Assets | $192.35M | $220.22M | $207.29M | $330.69M | $338.94M | $153.84M | $81.59M | $109.94M | $55.19M | — |
| Total Liabilities | $33.15M | $33.61M | $37.12M | $38.35M | $35.81M | $44.01M | $27.87M | $5.74M | $5.50M | — |
| Shareholders' Equity | $159.21M | $186.61M | $170.18M | $292.34M | $303.13M | $109.83M | -$60.37M | -$33.52M | -$26.95M | $0 |
| Cash & Equivalents | $38.92M | $56.49M | $159.71M | $257.66M | $277.54M | $84.33M | $10.61M | $9.47M | $53.35M | $0 |
| Operating Cash Flow | -$95.25M | -$92.38M | -$93.72M | -$44.77M | -$51.05M | -$41.55M | -$27.88M | -$18.18M | -$10.98M | — |
| Capital Expenditures | $1.74M | $1.12M | $4.46M | $16.78M | $13.05M | $990.0K | $1.07M | $876.0K | $44.0K | — |
| Shares Outstanding | 9.59M | 5.16M | 43.27M | 42.95M | 39.74M | 19.68M | 2.16M | 28.06M | 5.66M | — |
| Dividends Per Share | — | — | — | — | — | $0.00 | $0.00 | $0.00 | — | — |